Lnc-C/EBPβ Modulates Differentiation of MDSCs Through Downregulating IL4i1 With C/EBPβ LIP and WDR5

Myeloid-derived suppressor cells (MDSCs), which play an important role in tumor and inflammatory diseases, are divided into two subsets CD11b Ly6C Ly6G monocytic MDSC (Mo-MDSC) and CD11b Ly6C Ly6G polymorphonuclear MDSC (PMN-MDSC) with different immunosuppressive function. However, it is poorly unde...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2019-07, Vol.10, p.1661-1661
Hauptverfasser: Gao, Yunhuan, Shang, Wencong, Zhang, Dan, Zhang, Shiwu, Zhang, Xipeng, Zhang, Yuan, Yang, Rongcun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Myeloid-derived suppressor cells (MDSCs), which play an important role in tumor and inflammatory diseases, are divided into two subsets CD11b Ly6C Ly6G monocytic MDSC (Mo-MDSC) and CD11b Ly6C Ly6G polymorphonuclear MDSC (PMN-MDSC) with different immunosuppressive function. However, it is poorly understood the mechanism(s) to control differentiation of Mo-MDSCs and PMN-MDSCs. Here, we found that β may promote PMN-MDSC but impede differentiation of Mo-MDSCs and . We demonstrated that β mediated differentiation of MDSCs was through downregulating multiple transcripts such as IL4il. β not only bound to C/EBPβ isoform LIP to inhibit the activation of C/EBPβ but also interacted with WDR5 to interrupt the enrichment of H3K4me3 mark on the promoter region of IL4i1. Data also imply that conserved homo β has a similar function with mouse β. Since MDSC subsets exert different suppressive function, β may be acted as a potential therapeutic target for inflammatory and tumor-associated diseases.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2019.01661